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Summary
In mammals, the perception of pain is initiated by the
transduction of noxious stimuli through specialized
ion channels and receptors expressed by nociceptive
sensory neurons. The molecular mechanisms respon-
sible for the specification of distinct sensory modal-
ity are, however, largely unknown. We show here
that Runx1, a Runt domain transcription factor, is ex-
pressed in most nociceptors during embryonic devel-
opment but in adult mice, becomes restricted to noci-
ceptors marked by expression of the neurotrophin
receptor Ret. In these neurons, Runx1 regulates the
expression of many ion channels and receptors, in-
cluding TRP class thermal receptors, Na+-gated, ATP-
gated, and H+-gated channels, the opioid receptor
MOR, and Mrgpr class G protein coupled receptors.
Runx1 also controls the lamina-specific innervation
pattern of nociceptive afferents in the spinal cord.
Moreover, mice lacking Runx1 exhibit specific defects
in thermal and neuropathic pain. Thus, Runx1 coordi-
nates the phenotype of a large cohort of nociceptors,
a finding with implications for pain therapy.
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In mammals, noxious peripheral stimuli are conveyed
by nociceptors, a specialized group of primary sensory
neurons with high stimulus thresholds and with cell bod-
ies in the trigeminal and dorsal root ganglia (DRG) (Julius
and Basbaum, 2001; Lewin and Moshourab, 2004; Perl,
1984; Tominaga and Caterina, 2004). Nociceptive sen-
sory information is transmitted to the dorsal horn of the
spinal cord where it is processed, relayed to the brain,
and perceived as pain (Craig, 2003; Hunt and Mantyh,
2001; Light and Perl, 1979a, 1979b; Perl, 1998; Price
et al., 2003). The sensitization of nociceptors under path-
ological conditions contributes to chronic pain, a major
medical problem (Marchand et al., 2005; McMahon and
Jones, 2004; Scholz and Woolf, 2002; Woolf, 2004).
At a molecular level, nociceptors express a diverse ar-
ray of ion channels that transduce intense mechanical,
thermal, or chemical stimuli into electrical activity (Hunt
and Mantyh, 2001; Julius and Basbaum, 2001; Lewin
et al., 2004; Patapoutian et al., 2003; Wang and Woolf,
2005; Wood, 2004). These channels and receptors are
generally expressed in a partially overlapping or mutu-
ally exclusive fashion. For example, in the mouse DRG,
the cold receptor TRPM8 (McKemy et al., 2002; Peier
et al., 2002) and the heat/vanilloid receptor TRPV1 (Ca-
terina et al., 1997) segregate into different classes of
nociceptors (Story et al., 2003). Furthermore, a dozen
Mrgpr/SNSR class G protein coupled receptors (GPCRs)
are expressed in a largely mutually exclusive fashion, re-
vealing a previously unrecognized diversity of nocicep-
tors (Dong et al., 2001; Lembo et al., 2002; Zylka et al.,
2003, 2005).
To date, the molecular logic that governs the genera-
tion of nociceptor cell diversity is poorly understood.
However, several observations suggest a potential hier-
archical control of nociceptive neuron development. All
embryonic nociceptors initially express TrkA, a receptor
for the nerve growth factor or NGF (Huang and Reich-
ardt, 2001). During postnatal development, some noci-
ceptors extinguish TrkA and activate Ret expression,
a receptor for glial-cell-line-derived neurotrophic factor
(GDNF) (Molliver et al., 1997). TrkA+ and Ret+ afferents
terminate in distinct lamina and have been postulated
to mediate inflammatory and neuropathic pain, respec-
tively (Figure 1A) (Snider and McMahon, 1998). Consis-
tent with this view, several ion channels and receptors
are preferentially expressed in one of these two popula-
tions of nociceptors (Bradbury et al., 1998; Dong et al.,
2001; Potrebic et al., 2003; Zylka et al., 2003). Under-
standing how nociceptors segregate into TrkA+ and
Ret+ subclasses may therefore be an important step in
unraveling the logic behind nociceptor diversity.
Several transcription factors have been shown to con-
trol the development of nociceptive sensory neurons.
The neuronal determination gene Neurogenin1 (Ngn1) is
required for the formation of most nociceptors (Ma et al.,
1999). The homeobox gene Brn3a and the zinc-finger
gene Klf7 are required for the expression of the high af-
finity nerve growth factor (NGF) receptor TrkA and the
Neuron
366Figure 1. Runx1 Expression in the Develop-
ing and Adult DRG
(A) Differential expression of molecular
markers and lamina-specific innervations in
two classes of nociceptors. It has been pos-
tulated that IB4+;Ret+ (GDNF responsive)
nociceptors might mediate neuropathic pain,
whereas TrkA+ nociceptors (NGF responsive)
might be more critical for inflammatory pain
(Snider and McMahon, 1998).
(B) Transverse sections through E12 and
E14.5 DRG. Immunostaining of Runx1 (green)
and TrkA (red) was performed. Note that at
E12, no Runx1 expression is detected in
TrkA+ neurons. At E14.5, TrkA+ neurons ex-
press a high level (large arrow), a low level
(arrowhead), or none (small arrow) of Runx1.
Runx1+ neurons do not express Ret at this
stage (data not shown).
(C and D) Transverse sections through P30
DRG showing absence of double staining of
Runx1 protein (green) with TrkA mRNA (C,
red) but a colabel of Runx1 (green) with Ret
mRNA (D, red). Note that not all Ret+ neurons
coexpress Runx1 (D).
(E) Transverse sections through P30 DRG
showing that some DRG neurons express
TrkA alone (red), Ret alone (green), or both
TrkA and Ret (partially yellow). Triple staining
of TrkA, Ret, and Runx1 showed that some
Ret+ neurons express neither TrkA nor Runx1
(data not shown).
(F) In P30 DRGw60% Runx1+ neurons (green
in nuclei) showed positive staining with the
lectin IB4 (cell surface, red), a marker for a
subset of Ret+ nociceptors.
(G) Schematic indicating that Runx1 is ex-
pressed broadly in E14.5 TrkA+ neurons; its
expression persists in a subset of Ret+ neu-
rons but extinguishes in adult TrkA+ neurons.
TrkA expression also extinguishes in adult
Runx1+;Ret+ neurons. The origin, identity, and
function of Runx12;TrkA2;Ret+ cells remain
obscure.survival of nociceptors (Eng et al., 2004; Lei et al., 2005;
Ma et al., 2003; McEvilly et al., 1996). The mammalian
genome encodes three Runt domain transcription fac-
tors: Runx1/PEBP2aB/AML1, Runx2/PEBP2/AML3, and
Runx3/PEBP2bC/AML2 (de Bruijn and Speck, 2004).
These Runt proteins interact with a common cofactor
CBFb to control a variety of developmental processes
(de Bruijn and Speck, 2004; Komori, 2005; Stein et al.,
2004). Both Runx1 and Runx3 are expressed in the tri-
geminal and dorsal root ganglia (Inoue et al., 2002; Leva-
non et al., 2002; Theriault et al., 2004). Runx3 is involved
in the differentiation of proprioceptive sensory neurons
(Inoue et al., 2002; Levanon et al., 2002), whereas Runx1
expression appears to be restricted to nociceptors
(Levanon et al., 2002; Theriault et al., 2004).
Despite this progress, transcription factors that are
responsible for the segregation of TrkA+ and Ret+ noci-
ceptors and/or the expression of nociceptive transduc-
tion ion channels have not yet been characterized. As
a consequence, it has been unclear whether the special-
ized sensory modalities of individual classes of nocicep-
tive sensory neurons are established independently
or through a more coherent molecular program. In this
study, we show that the persistent expression of Runx1marks nociceptors that undergo the developmental TrkA
to Ret transition, and in mice that selectively lack Runx1
function in the peripheral nervous system, the TrkA
to Ret transition is impaired. Moreover, we find that
Runx1 is required to activate or suppress the expression
of a large cohort of nociceptive ion channels and sensory
receptors. In addition, Runx1 is required to target affer-
ent projections to specific lamina in the dorsal spinal
cord. Finally, behavioral analyses demonstrate specific
deficits in thermal and neuropathic pain in Runx1 defi-
cient mice. These findings suggest that Runx1 coordi-
nates the phenotype of a large set of nociceptors.
Results
Persistent Runx1 Expression Marks a
Subset of Ret+ Nociceptors
To examine the involvement of Runx1 in sensory neuron
differentiation, we first examined its expression profile
during the developmental period that nociceptor sub-
types emerge. TrkA expression is initiated at embryonic
day 11.5 (E11.5) and detected robustly in E12 lumbar
DRG neurons, whereas Runx1 expression is only first
detected at E12.5 (Figure 1B and data not shown).
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367Figure 2. Conditional Knockout of Runx1 in
the DRG
(A) The schematics of the conditional allele.
Exon 4, encoding part of the DNA binding
Runt domain, is flanked with two loxP se-
quences (black triangles). Deletion of this
exon is known to generate a null allele. The
neo cassette in the intron region was also
flanked with loxP sites. After crossing with
Wnt1-Cre mice, the neo cassette and exon 4
were removed by Cre-mediated DNA recom-
bination.
(B) Immunostaining of Runx1 on sections
through control Runx1F/F (left) and Runx1F/F
Wnt1-Cre (right) DRG at E13.5. Note a nearly
complete loss of Runx1 protein in Runx1F/F
Wnt1-Cre DRG.
(C) Average (6 SEM) neuronal numbers in the
fifth lumbar (L5) DRG ofRunx1F/FandRunx1F/F
Wnt1-Cre mice are shown. No significant dif-
ference was detected (p > 0.05, with p < 0.05
considered as significant). Expression of the
panneuronal marker SCG10, detected by in
situ hybridization, was used to count neurons.From E14.5 to postnatal day zero (P0), Runx1 expres-
sion is restricted to TrkA+ neurons (Figure 1B), and
about 88% of TrkA+ neurons express either a high or
low level of Runx1 (Figure 1B, large arrow versus arrow-
head). By postnatal day (P) 6.5, an extinction of TrkA ex-
pression in some Runx1+ neurons becomes apparent
(data not shown). By P30, most Runx1+ neurons no lon-
ger coexpress TrkA (Figure 1C) and instead colocalize
with Ret (Figure 1D). However, not all Ret+ neurons
coexpress Runx1 (Figure 1D). Double staining of TrkA
and Ret defines then three subclasses of adult DRG
neurons: Ret+, TrkA+, and TrkA+Ret+ (Figure 1E). We
conclude that persistent Runx1 expression marks those
neurons that undergo a late developmental transition
from a TrkA+ to a Ret+ status (Figure 1G). Runx1 expres-
sion is extinguished, however, in DRG neurons that re-
main TrkA+ in the late postnatal period.
Generation of Runx1 Conditional Knockout Mice
To examine the influence of Runx1 on the differentiation
of nociceptive sensory neurons, we examined the phe-
notype of conditional Runx1 knockout mice. Mice carry-
ing a loxP-based conditional Runx1 allele (Growney
et al., 2005) (referred here to as Runx1F) (Figure 2A)
were crossed with a Wnt1-Cre mouse strain that directs
Cre expression in premigratory neural crest cells, includ-
ing progenitors of DRG neurons (Jiang et al., 2000). In
Runx1F/F;Wnt1-Cre (for simplicity, Runx1–/–) mice, there
is no detectable expression of Runx1 in DRG neurons at
E13.5 (Figure 2B) or in adult DRG (data not shown), sug-
gesting a nearly complete penetration of Cre-mediated
recombination. Runx1–/– mice are viable and fertile with
no overt abnormalities. Moreover, DRG neuron numbers
are similar in Runx1–/– and control Runx1F/F mice (Fig-
ure 2C), indicating thatRunx1 is not required for the gen-
esis or survival of DRG neurons.
Impaired Transition from TrkA+ to Ret+
Nociceptors in Runx1–/– Mice
In Runx1–/– mice, we observe a dramatic change in the
proportions of TrkA+ and Ret+ neurons (Figure 3). At
P60, the percentage of TrkA+ neurons in lumbar DRGis increased from 28% 6 3% in Runx1F/F control mice
to 69% 6 6% in Runx1–/– mice (p < 0.001, with p < 0.05
considered as significant) (Figures 3A, 3B, and 3I), and
conversely, the percentage of Ret+ DRG neurons de-
creases from 69% 6 6% to 30% 6 2% (p < 0.001) (Fig-
ures 3C, 3D, and 3I). An incomplete loss ofRet is consis-
tent with our finding that not all Ret+ neurons coexpress
Runx1 (Figure 1D).
The change in the proportions of TrkA+ and Ret+ neu-
rons could result from a fate transformation from Ret+ to
TrkA+ or a selective loss of Ret+ neurons followed by
a compensatory reduction in the death of TrkA+ neu-
rons. To distinguish between these two possibilities,
we assessed the phenotype of neurons that label with
the lectin IB4 in Runx1–/– DRG. In wild-type DRG, a sub-
set of Ret+ neurons colabels with IB4 andw90% of IB4+
neurons coexpress Runx1, whereas TrkA+ neurons
rarely label with IB4 (Figures 1F, 3E, and 3G) (Molliver
et al., 1997). The percentage of IB4-labeled neurons in
lumbar DRG is unchanged between Runx1–/– mice
(30% 6 4%) and control mice (31% 6 5%) (p = 0.42),
but most IB4+ neurons no longer express Ret and in-
stead express TrkA in Runx1–/– mice (Figures 3F and
3H). These findings suggest that Runx1 is required for
the developmental transition from a TrkA+ to a Ret+ phe-
notype, by suppressing TrkA and promotingRet expres-
sion (summarized in Figure 3J).
Loss of Nociceptive Ion Channels and Sensory
Receptors in Runx1–/– Mice
The expression of high threshold ion channels defines
the specialized peripheral receptive properties of noci-
ceptor subclasses (Hunt and Mantyh, 2001; Jordt
et al., 2003; Julius and Basbaum, 2001; Lewin et al.,
2004; Patapoutian et al., 2003; Wood, 2004). To deter-
mine ifRunx1 is required for the specification of different
transduction phenotypes, we compared the expression
of nociceptive ion channels and sensory receptors in
Runx1–/– and control Runx1F/F mice.
TRP class ion channels transduce a wide range of
thermal stimuli, including noxious cold or heat (Jordt
et al., 2003; Patapoutian et al., 2003; Wang and Woolf,
Neuron
368Figure 3. Transformation of Ret+ into TrkA+
Nociceptors in Runx1–/– Mice
Transverse sections through adult DRG
(A–H). (A-D) In situ hybridization with TrkA
or Ret probes. (E and F) Double labeling for
IB4 binding (green) and Ret mRNA (red) on
adult DRG sections. Note that in control
Runx1F/F DRG, IB4+ cells coexpress Ret (E,
arrow), but in adult Runx1–/– DRG, most IB4+
neurons lose Ret expression (F, arrow). (G
and H) Double labeling for IB4 binding (red)
and TrkA protein (green) on adult DRG sec-
tions. IB4+ cells do not express TrkA in con-
trol Runx1F/F DRG, but they do in Runx1–/–
DRG. (I) Average (6 SEM) percentages of
DRG neurons expressing the molecular
markers in control Runx1F/F and Runx1–/–
mice are shown. (J) Schematic of the trans-
formation of prospective Ret+ into TrkA+
nociceptors in mutants (in comparison with
the situation occurring in wild-type DRG,
Figure 1G). In Runx1–/– mice, all nociceptors
retain TrkA expression, although the ‘‘trans-
formed’’ cells retain IB4 staining.2005). Expression of two putative cold receptors TRPM8
and TRPA1 is first detected at E16.5 in wild-type DRG
(data not shown); however, their expression is absent
at every stage examined in Runx1–/– mice (E16.5, P0,
P7, P30, and P60) (Figure 4A and see also below Figure 5;
data not shown), indicating that Runx1 is required to ini-
tiate the expression of these transduction molecules.
Expression of the heat receptors TRPV1 and TRPV2, as
well as TRPC3, is also eliminated or markedly reduced in
adult Runx1–/– DRG (Figure 4A). The percentage of L4
and L5 DRG neurons expressing a high level of TRPV1
is reduced from 2.6% 6 0.5% to none (p < 0.01) and
TRPV2 (high level) from 25% 6 3% to 6% 6 1% (p <
0.001) (Figure 4A). However, the number of neurons
that express an intermediate level of TRPV1 is not
reduced (Figure 4A; data not shown), implying that
Runx1 is required for elevated but not basal levels of ex-
pression of this heat receptor. The Mrgpr genes (Mrg/
SNSR) encode a dozen GPCRs that are expressed ex-
clusively in Ret+;IB4+ nociceptors (Dong et al., 2001;
Lembo et al., 2002; Zylka et al., 2003; Zylka et al.,
2005), and activation of Mrgprc/SNSR1 in rat causes hy-
persensitivity to heat and mechanical stimuli (Grazzini
et al., 2004). In Runx1–/– mutants, expression of Mrgprd,
Mrgprb4, and Mrgprb5 is absent at every stage exam-
ined (Figure 4B), whereas expression of other Mrgpr
genes, including Mrgpra1-a8 and Mrgprc, is markedly
reduced in Runx1–/– DRG (C.-L.C. and Q.M., unpub-
lished data).
ATP released from damaged tissue evokes a painful
response by activating ATP-gated channels (P2Xs)
(Wood, 2004). The percentage of neurons expressing the
nociceptor-specific P2X3 channel (Chen et al., 1995) is
markedly reduced in Runx1–/– DRG (from 32% 6 3% to
13%6 2%; p < 0.001) (Figure 4D). In addition, high-level
expression of the tetrodotoxin-resistant Na+ channel
gene Nav1.9/SNS2, which contributes to nociceptor
membrane excitability (Dib-Hajj et al., 1998; Wood et al.,
2004), is virtually eliminated, from 28% 6 3% in control
DRG to less than 0.1% in Runx1–/– DRG (p < 0.001)(Figure 4C). Furthermore, at P30, Runx1 protein is de-
tected in the majority of wild-type DRG neurons that ex-
press TRPC3, P2X3, Nav1.9, or Mrgprd (Figure 4E), sug-
gesting that Runx1 may control the expression of these
channels in a cell-autonomous manner.
In contrast, expression of ASIC, encoding a proton-
gated ion channel (Waldmann and Lazdunski, 1998), is
unchanged (19% 6 1% in Runx1F/F control mice versus
18%6 1% inRunx1–/– mice; p > 0.05) (see below Figures
5C and 5D). Likewise, no obvious reduction is observed
in the expression of another TTX-resistant channel
Nav1.8/SNS, which is expressed in a majority of noci-
ceptors in mouse DRG (Agarwal et al., 2004) (data not
shown). We conclude that Runx1 coordinates the ex-
pression of many but not all nociceptive transduction
ion channels and receptors, ranging from thermal recep-
tors, ATP-gated and Na+-gated channels, as well as a
large family of GPCRs.
Derepression in Runx1–/– DRG Neurons
In Runx1–/– DRG, presumptive Ret+ neurons transform
into TrkA+ neurons. This led us to examine if the expres-
sion of genes, which in wild-type DRG are preferentially
associated with a TrkA+ identity, is also affected in
Runx1 mutants. Most adult TrkA+ neurons are peptider-
gic and express the genes encoding the precursors for
the neuropeptides Substance P (SP) and Calcitonin
Gene Related Peptide (CGRP) (Snider and McMahon,
1998). From E16.5 to P30 in wild-type DRG, CGRP+ neu-
rons either do not express or express a low level of
Runx1 (Figure 5A). InRunx1–/– adult mice, however, there
is a marked increase in the percentage of DRG neurons
expressing CGRP, from 32% 6 2% to 64% 6 2% (p <
0.001) (Figures 5B and 5D). SP+ neurons also shows a
significant, albeit more modest, increase from 32% 6
4% to 43% 6 2% (p < 0.0001) (Figures 5B and 5D). The
expansion of CGRP in Runx1–/– mice is also apparent
by the detection of CGRP expression in IB4+ neurons
(Figure 5B), which is only very rarely observed in wild-
type DRG (Figure 5B). Together, these findings suggest
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369Figure 4. Regulation of Nociceptive Ion Channels and Sensory Receptors by Runx1
(A–D) Sections through adult control Runx1F/F and Runx1–/– DRG and in situ hybridization performed with indicated probes. Note the loss or
marked reduction of diverse ion channels and receptors in Runx1–/– mice. Note a selective reduction of high-level (arrows) but not the interme-
diate expression (arrowheads) of TRPV1 or TRPV2.
(E) Double labeling of Runx1 protein (green) and indicated probes (red) on adult wild-type P30 DRG sections. Note that Runx1 was expressed in
the majority of neurons expressing TRPC3, Mrgprd, P2X3, or Nav1.9/SNS2 (red). Runx1 expression is, however, not detected in a small fraction
of P2X3+, Mrgprd+, or Nav1.9+ neurons.that in absence of Runx1, prospective nonpeptidergic
nociceptors develop into CGRP+ peptidergic neurons.
The DRG acid-sensing channel DRASIC and the mu-
class opioid receptor are associated preferentially with
peptidergic identity (Li et al., 1998; Price et al., 2001).
Consistently, in adult wild-type DRG Runx1+ neurons
do not express DRASIC (Figure 5A). In Runx1–/– adult
mice, there is, however, a marked increase in the per-
centage of DRG neurons expressing MOR (from 33% 6
2% to 63% 6 3%; p < 0.001) or DRASIC (from 22% 6
2% to 71% 6 5%; p < 0.001) (Figures 5C and 5D).
Thus, within presumptive Ret+ neurons, Runx1 is re-
quired to suppress the expression of a set of molecules
normally associated with a TrkA identity (summarized in
Figure 5E).
Runx1 Activates Expression of Some Ion Channels
before It Acts to Switch off TrkA or Activate Ret
Runx1 is required to regulate the expression of both
neurotrophin receptors and nociceptive ion channels(Figures 3–5). To determine if the loss/expansion of ion
channels is caused by a change in neurotrophin-recep-
tor signaling, we examined when Runx1 exerts these
two activities. Expression of TRPM8 and Mrgprd is first
detected at E16.5 in wild-type DRG (Figures 6A and 6C;
data not shown), and this expression is eliminated in
Runx1–/– DRG at E16.5 (Figures 6B and 6D). A marked re-
duction of expression of TRPV1 and TRPA1 is also ob-
served at P0 in Runx1–/– DRG (data not shown). How-
ever, at every embryonic or neonatal stage examined
(E14.5, E17, and P0), nearly all Runx1+ neurons in wild-
type DRG express TrkA (Figure 6E; data not shown).
This suggests that Runx1 is required to activate chan-
nel/receptor expression at prenatal/neonatal stages be-
fore it acts to switch off TrkA expression at postnatal
stages. By E17, Ret expression becomes apparent in
a subpopulation of Runx1+ neurons (Figure 6F). At this
stage, however, TRPM8+ neurons do not coexpress Ret
(Figures 6G–6I), suggesting that initiation of TRPM8 ex-
pression is independent of Ret-mediated signaling.
Neuron
370Figure 5. Derepression in Runx1–/– Mice
(A) Double labeling of Runx1 protein (green)
and CGRP and DRASIC mRNA (red) on
E16.5 or P30 DRG sections. Runx1+ neurons
do not express CGRP at E16.5 or DRASIC at
P30 (arrows), but some CGRP+ neurons ex-
press a low level of Runx1 at P30 (arrow-
head).
(B, top, and C) In situ hybridization was per-
formed on sections through adult wild-type
and Runx1–/– DRG with indicated probes. (B,
bottom) Double staining of CGRP mRNA
(red) and IB4 binding (green). Most IB4+
neurons in control Runx1F/F P30 DRG do not
express CGRP (arrow, left), although a small
number of IB4+ neurons do (arrowhead,
left). In Runx1–/– DRG, many IB4+ neurons
now coexpress CGRP (right, arrow), although
some mutant IB4+ neurons still lack CGRP
(right, arrowhead).
(D) Average (6 SEM) percentages of DRG
neurons expressing the molecular markers
in wild type and Runx1–/– mice are shown (as-
terisk, t test, p < 0.001).
(E) Runx1 activates and suppresses two sep-
arate groups of neuropetides, ion channels
and sensory receptors.Thus, the loss of many nociceptive ion channels in
Runx1–/– DRG neurons is unlikely to be explained solely
by the loss of Ret or the gain of TrkA expression, which
in turn implies a more direct function for Runx1 in con-
trolling the expression of these channels and receptors.
Central Afferent Targeting Is Impaired
in Runx1 Mutants
The precision in processing sensory information de-
mands coordination between the specification of sen-
sory modality and afferent central target selection. To
determine if Runx1 coordinates these two developmen-
tal processes, we examined afferent projections in the
dorsal spinal cords of wild-type and Runx1–/– mice. In
wild-type mice, IB4+ (Ret+) afferents project predomi-
nantly to inner lamina II (IIi) (Figures 7A and 7G, arrows
and Figure 7Q), whereas CGRP+ and SP+ peptidergic
afferents (TrkA+) predominantly project to lamina I and
outer layer II (IIo) (Figures 7C, 7G, and 7K, arrowheads)
and, to a lesser extent, to lamina IIi (Figures 7C, 7G,
and 7K, arrows) (Snider and McMahon, 1998). InRunx1–/–
mice, IB4+, CGRP+, and SP+ afferents all reach the dor-
sal horn (Figures 7B, 7D, and 7J), suggesting that initial
axon pathfinding from the DRG to the spinal cord is in-
dependent of Runx1. However, double labeling of IB4
and CGRP or SP clearly shows a shift in IB4+ afferentinnervation from the more ventral lamina to the most
dorsal lamina of the dorsal horn (Figure 7H versus Fig-
ure 7G), whereas CGRP+ afferents (Figures 7D and 7H
versus Figure 7C and 7G) and SP+ afferents (Figures 7J
and 7L versus Figures 7I and 7K) still project predomi-
nantly to the most superficial lamina. The dorsal shift
in IB4+ afferent innervation is also supported by the dou-
ble labeling of IB4 and PKC-g (Figures 7M–7P). In wild-
type mice, IB4+ afferents terminate in the lamina exactly
abutting the territory enriched with PKC-g-positive neu-
ronal cell bodies and processes (Figures 7M and 7O),
but in Runx1–/– mice, the density of IB4+ afferents in
this area is much reduced (Figures 7N and 7P versus
Figures 7M and 7O, arrows).
In the dorsal horn of Runx1–/– mice, a subset of IB4+
afferents costains with CGRP (Figure 7H, arrow) and to
a lesser extent with SP (Figure 7L, arrow), something
rarely seen in wild-type mice (Figures 7G and 7K). This
difference in colabeling with CGRP and SP is consistent
with their dramatic (CGRP) and modest (SP) derepres-
sion inRunx1–/– IB4+ neurons (Figure 5). However, within
the superficial dorsal lamina of Runx1 mutant mice,
some afferents express only CGRP or SP and do not la-
bel with IB4 (Figures 7H and 7L, arrowheads). This sug-
gests that endogenous peptidergic afferents project
normally in Runx1–/– mice. We conclude that a loss of
Nociceptive Transduction Phenotype Specification
371Runx1 appears to specifically perturb the laminar target
selection of IB4+ afferents (summarized in Figures 7Q
and 7R).
Deficits in Thermal and Neuropathic Pain
To examine if the molecular and anatomical defects in
Runx1–/– mice are accompanied by alterations in behav-
ioral responses to noxious stimuli, we assayed acute re-
sponses to noxious thermal and mechanical stimuli, as
well as neuropathic and inflammatory pain sensitivity.
Runx1mutants exhibit a significantly delayed reaction
time to a noxious heat stimulus (50ºC, 52ºC, and 55ºC
hot plate) that is most evident at the lowest stimulus
temperature (Figures 8A and 8B; data not shown). There
is also a markedly diminished response to a cold stimu-
lus (acetone evaporation) by Runx1–/– mice (Figure 8C).
TRPV1 also serves as the receptor for capsaicin, the
pungent ingredient in chili pepper (Jordt et al., 2003).
Figure 6. Runx1 Is Required to Activate Ion-Channel/Receptor Ex-
pression before It Controls Neurotrophin-Receptor Expression
(A–D) In situ hybridization on sections through E16.5 controlRunx1F/F
and Runx1–/– DRG.
(E and F) Double immunostaining of Runx1 protein (green) with TrkA
protein (E, red) or Ret protein (F, red) in E17 wild-type DRG. Note
effectively all Runx1+ neurons coexpress TrkA at this stage (E), but
only a subpopulation of Runx1+ neurons express Ret (F).
(G–I) Double staining of TRPM8 mRNA (green) and Ret protein (red)
showed a lack of Ret expression in TRPM8+ neurons in E17 DRG.In agreement with the loss of high-level expression of
TRPV1, capsaicin-induced pain responses, as indicated
by paw licking, flinching, and foot withdrawal (Caterina
et al., 2000), are significantly reduced in Runx1–/– mice
(Figure 8D). In marked contrast, we detected no change
in the sensitivity of Runx1–/– mice to threshold mechan-
ical noxious stimuli or to suprathreshold pinprick stimuli
(Figures 8E and 8F), indicating that mechanical pain is
not grossly altered by the loss of Runx1 function. These
findings establish a specific requirement for Runx1 ac-
tivity in sensory neurons for the detection of acute ther-
mal, but not mechanical, noxious stimuli.
Neuropathic pain represents a heightened pain sen-
sitivity induced by peripheral nerve injury, in which
normally innocuous tactile stimuli can evoke pain or
pain-like withdrawal response, a phenomenon termed
mechanical allodynia (Woolf, 2004). We used the spared
nerve injury model (SNI) (Decosterd and Woolf, 2000) to
assess if neuropathic pain is affected in Runx1–/– mice.
In control Runx1F/F mice, nerve injury induces mechani-
cal allodynia, indicated by a substantial lowering of
the paw withdrawal threshold (ANOVA interaction:
F[8,80] = 3.14, p < 0.01) (Figure 8G). After SNI in
Runx1–/– mice no change in paw withdrawal threshold
is detected (p > 0.05), indicating an absence of mechan-
ical allodynia. Thus, Runx1 function is necessary for the
manifestation of neuropathic pain responses.
Inflammatory pain occurs in response to peripheral
tissue inflammation. We assessed if Runx1 function
is involved in establishment of inflammatory pain re-
sponses by monitoring mechanical allodynia after intra-
plantar injection of complete Freund’s adjuvant (CFA).
CFA-induced inflammation occurred normally, as indi-
cated by the swelling of the entire feet and hind legs in
both Runx1–/– and control Runx1F/F mice (for quantita-
tive data, see Experimental Procedures). However, al-
though mechanical allodynia was still induced in the in-
flamed hindpaw, the degree of allodynia is significantly
less in Runx1–/– than in control Runx1F/F mice (ANOVA
interaction: F[1,21] = 23.556, p < 0.001) (Figure 8H).
Runx1 may therefore have a role, albeit relatively minor,
in the development of inflammatory pain.
Discussion
Roles of Runx1 in the Specification of TrkA+
and Ret+ Nociceptor Cell Fates
Three lines of evidence suggest that Runx1 function is
required for the proper segregation of Ret+ and TrkA+
nociceptors. First, persistent expression of Runx1
marks those neurons that extinguish TrkA and switch
on Ret, and a loss of Runx1 in DRG sensory neurons re-
sults in a reduction in Ret+ neurons and a reciprocal in-
crease in TrkA+ neurons. Second, many genes that are
expressed in Ret+;IB4+ neurons, including P2X3 and
Mrgpr class GPCR genes (Bradbury et al., 1998; Dong
et al., 2001; Zylka et al., 2003), are eliminated in Runx1–/–
mice, whereas others preferentially expressed in TrkA+
neurons, including CGRP, DRASIC, and MOR (Li et al.,
1998; Price et al., 2001), are expanded. Third, in wild-
type mice, IB4+ (Ret+) afferents project to the deep lam-
ina of the dorsal horn, whereas in Runx1–/– mice, IB4+
afferents project to the most superficial lamina, which
normally are only innervated by TrkA+ peptidergic
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Double staining of IB4 (A, B, and E–P, green) plus CGRP (C–H, red), SP (I–L, red), or PKC-g (M–P, red) on P30 dorsal horn sections. (E) and (F) are
the merged images shown in (A) – (D). (G), (H), (K), (L), (O), and (P) represent a higher magnification. (Q and R) Schematics showing the change
of lamina-specific innervation of IB4+ afferents: from a deep lamina in wild-type dorsal horn (Q, red) to a more superficial lamina in Runx1–/– mice
(R, red).afferents. The Ret+ to TrkA+ cell-fate transition is, how-
ever, incomplete because IB4 labeling and expression
of SP, markers for Ret+ and TrkA+ neurons, respectively,
either persist or only show a modest expansion. Runx1
is therefore a major, albeit not the sole, determinant
of Ret+ nociceptor cell fate. Our studies suggest that
peptidergic nociceptors may represent a ground differ-
entiation state, established in the absence of Runx1. In
C. elegans, mutations in several transcription factors
causes a partial transformation of diverse types of sen-sory neurons into a ‘‘default’’ chemosensory neuron fate
(Lanjuin and Sengupta, 2004), suggesting that some of
the logic governing sensory neuron diversification has
been conserved during evolution.
Runx1 is initially expressed broadly in embryonic no-
ciceptor neurons, but its expression is extinguished se-
lectively in adult TrkA+ neurons. The ability of Runx1 in
suppressing many features associated with TrkA+ neu-
rons explains the necessity for its downregulation. How-
ever, it should be pointed out that TRPA1, expression of
Nociceptive Transduction Phenotype Specification
373Figure 8. Pain Behavioral Deficits in Runx1 Mutant Mice
(A–F) Behavioral sensitivity of control Runx1F/F mice (open bars) and Runx1–/– mice (hatched bars) in tests of heat (hotplate) (A and B), cold
(acetone evaporation) (C), Capsaicin-mediated (D), and mechanical pain measured with Von Frey hair (E) or pinprick stimuli (F). For (A)–(C),
(E), and (F), n = 19 for control Runx1F/F, and n = 16 for mutant groups. For (D), n = 7 for both control Runx1F/F and mutant groups. Asterisk
p < 0.05, double asterisk p < 0.01, and triple asterisk p < 0.001.
(G and H) Mechanical allodynia in control Runx1F/F and Runx1–/– mice in the spared nerve injury (SNI) model of neuropathic pain and (H) intra-
plantar complete Freund’s adjuvant (CFA) model of inflammatory pain. n = 6 each group for SNI (G), and n = 13 control Runx1F/F mice, and n = 10
Runx1–/– groups for CFA (H). All data in (A)–(F) and (H) are presented as average (6 SEM). Error bars in (G) show the actual range of the data.
Double asterisk p < 0.01 and triple asterisk p < 0.001 compared to baseline and triple dagger p < 0.001 to control Runx1F/F mice.which is eliminated in Runx1–/– mice, is associated ex-
clusively with peptidergic, and thus presumably TrkA+,
neurons (Story et al., 2003). Therefore, although persis-
tent Runx1 expression promotes a Ret+ over a TrkA+
cell fate, its transient expression in peptidergic neurons
also plays a role for the specification of certain transduc-
tion phenotypes.
Coordinated Regulation of Nociceptive
Transduction Phenotypes
Our data suggest that specificity of expression of noci-
ceptive ion channels/receptors in distinct nociceptors
is subject to coordinated transcriptional control. First,
Runx1 is required to activate and to suppress separate
groups of ion channels and receptors (Figure 5E). Sec-
ond, many Runx1-dependent channels, including TRP
thermal channels and Mrgpr class GPCRs, are ex-
pressed in a partially overlapping or nonoverlapping
fashion (Dong et al., 2001; Lembo et al., 2002; Story
et al., 2003; Woodbury et al., 2004; Zylka et al., 2003,
2005). Third, a recent genome-scale screen of transcrip-tion factors (TFs) expressed in the nervous system (Gray
et al., 2004) so far fails to identify TFs that are expressed
in a subset of IB4+;Runx1+ neurons (C.-L.C. and Q.M.,
unpublished data), despite the tremendous diversity of
this group of neurons (Dong et al., 2001; Zylka et al.,
2003), implying that determination of nociceptor pheno-
type might be controlled by a limited number of TFs.
Coordinated regulation of diverse sensory channels/
receptors appears to be a common theme. In the mam-
malian olfactory system, each olfactory neuron ex-
presses one of a 1,000 olfactory receptors (ORs) (Mom-
baerts, 2004; Shykind, 2005). Recent genetic studies,
however, demonstrate that each olfactory neuron is
competent to activate any of several hundred ORs ex-
pressed in the same zone of the olfactory nasal epithe-
lium, implying a coordinated but somehow stochastic
control mechanism (Lewcock and Reed, 2004; Serizawa
et al., 2003; Shykind et al., 2004). Transcription factors
responsible for OR expression, however, have not been
characterized. Therefore, the demonstration that Runx1
is required for the expression of many nonoverlapping
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374nociceptive ion channels/receptors provides an impor-
tant steppingstone to unravelling the logic behind sen-
sory neuron diversity.
Coordination between the Specification of Sensory
Modality and Central Target Selection
In Ret+;IB4+ nociceptors, Runx1 controls both the ex-
pression of nociceptive ion channels (Figures 4–6) and
central afferent target selection (Figure 7). A requirement
for afferent target selection, but not initial axon pathfind-
ing, appears to be an evolutionally conserved function
for Runt domain proteins. In Runx3–/– mice, muscle af-
ferents enter the spinal cord but fail to reach their targets
in the ventral horn and in the intermediate spinal cord
(Inoue et al., 2002; Levanon et al., 2002). In the Drosoph-
ila visual system, the Runt protein Run is expressed in
R7 and R8 photoreceptors that innervate the distal layer
(the medulla) in the optic lobe, whereas R1–R6 photore-
ceptors that lack Run innervate the proximal layer (the
lamina) (Kaminker et al., 2002). Ectopic expression of
Run in R2 and R6 is sufficient to cause these neurons
to switch their projections from the lamina to the me-
dulla (Kaminker et al., 2002).
How might Runx1 coordinate sensory modality spec-
ification and afferent target selection? In the olfactory
system, axon targeting involves olfactory receptors
(Reed, 2004). However, available genetic data do not
suggest that nociceptor ion channels or receptors are
required for central target selections (Caterina et al.,
2000; Zylka et al., 2005). One possibility, therefore, is
that Runx1 may also control the expression of molecules
responsible for afferent target selection. In this regard, it
is noteworthy that at embryonic stages, CGRP expres-
sion is associated exclusively with neurons that express
low or negligible levels of Runx1 (Figure 5; data not
shown), and CGRP+ afferents project to the most super-
ficial lamina. Furthermore, in the absence of Runx1, IB4+
afferents switch their projections from lamina IIi to the
most superficial lamina. These data suggest that a low
level of Runx1 in nociceptive sensory neurons may con-
fer a proximal laminar projection, whereas high levels of
Runx1 may confer distal projections.
Association of a Runx1-Mediated Differentiation
Program with Specific Pain Behaviors
Runx1 function is required specifically for thermal and
neuropathic pain but not for mechanical pain. The pain
defect in Runx1–/– mice could be caused by loss of ex-
pression of nociceptive ion channels, alterations in cen-
tral connectivity, or both. Despite this complexity, TRP
channels have been implicated in noxious cold and
heat pain sensitivity (Jordt et al., 2003; Wang and Woolf,
2005), and their loss or reduction likely contributes to the
heat and cold pain deficits observed in Runx1–/– mice.
The loss of a high level of TRPV1 expression might
also contribute to the deficit of capsaicin-induced
pain. The prominent roles of Runx1 for the development
of Ret+ nociceptors and the dramatic loss of neuro-
pathic pain inRunx1–/– mice are consistent with previous
findings that the GDNF family of neurotrophins, which
signals through Ret, has a therapeutic effect on neuro-
pathic pain (Boucher et al., 2000; Gardell et al., 2003;
Malmberg et al., 1997; McMahon and Jones, 2004;
Snider and McMahon, 1998), although we can not ruleout that a defect in peptidergic neurons, as implicated
by the loss of TRPA1, may contribute to the behavioral
phenotypes.
The normal response of Runx1–/– mice to noxious
mechanical stimuli implies that Runx1-independent ion
channels could serve as the candidates for still elusive
noxious mechanic transducers. The absence of TRPA1
expression in Runx1–/– mice rules out that TRPA1 func-
tions as an exclusive mechanotransducer in nocicep-
tors, even though it has a role in mechanotransduction
in the vestibular apparatus and cochlea (Corey et al.,
2004; Nagata et al., 2005). Genetic ablation of DRASIC
results in a reduction of mechanosensitivity in nocicep-
tors, but DRASIC mutant mice do not show obvious me-
chanical pain deficits (Price et al., 2001). However, it re-
mains a formal possibility that the derepression of
DRASIC in Runx1–/– mice may confer some nociceptors
a new capacity to mediate noxious mechanical stimuli.
Analogous Functions of Runx Proteins in
Controlling Nociceptor and T Cell Development
In the immune system, Runx proteins segregate two ma-
jor classes of T cells, CD4+ and CD8+, by suppressing
CD4 and activating CD8 expression (de Bruijn and
Speck, 2004; Taniuchi and Littman, 2004; Taniuchi
et al., 2002). This is, in many ways, analogous to the
role of Runx1 in controlling the segregation of TrkA+
and Ret+ nociceptors: suppressing TrkA and activating
Ret. In addition, Runx1 is required for the expression
of a variety of T cell receptors, including the rearrange-
ment/expression of TCR-b and the subsequent emer-
gence of the T cell diversity (de Bruijn and Speck,
2004; Taniuchi and Littman, 2004; Taniuchi et al.,
2002). Runx1 is therefore associated with the generation
of the diversity of cells that respond to noxious stimuli or
pathogen infection, two innate defense systems that
have evolved to enhance animal survival.
Conclusion
Mammalian nociceptive sensory neurons process an
diverse range of peripheral noxious stimuli, a repertoire
endowed by virtue of their expression of distinct ion
channels and receptors that serve as selective sensory
transducers. In principle, the specialized sensory mo-
dalities of individual classes of nociceptive sensory neu-
rons could be established independently and in piece-
meal fashion. Our data, however, provide strong
evidence that Runx1 is required to specify the receptive
properties of a large cohort of nociceptive sensory neu-
rons. Furthermore, the dual functions of Runx1 in con-
trolling sensory modality specification and afferent cen-
tral target selection form a genetic basis for the
assembly of specific neural circuits for nociceptive infor-
mation processing. Finally, the identification of a core
transcriptional control program for many of the ion
channels and receptors known to transduce noxious
stimuli has intriguing implications for the design of
more effective pain therapies.
Experimental Procedures
Animals
The generation of Runx1 conditional mutant and Wnt1-cre trans-
genic mice has been described previously (Growney et al., 2005;
Nociceptive Transduction Phenotype Specification
375Jiang et al., 2000). The morning that vaginal plugs were observed
was considered as E0.5. PCR-based genotyping was performed
with the following primers: for Wnt1-Cre allele, 50-TAT CTC ACG
TAC TGA CGG TG-30 and 50-CTA GTC TAG ACT AAT CGC CAT
CTT CCA GC-30; for Runx1 wild-type and floxed alleles, 50-GAG
TCC CAG CTG TCA ATT CC-30 and 50-GGT GAT GGT CAG AGT
GAA GC-30, with floxed allele showing a larger size of DNA band after
gel electrophoresis.
In Situ Hybridization and Immunostaining
Detailed protocols for section in situ hybridization are available upon
request. The following mouse in situ probes, TRPA1 (0.9 kb), TRPM8
(0.71 kb), TRPV1 (0.72 kb), TrkA (0.7 kb), TRPV2 (0.8kb), DRASIC
(1.0kb), P2X3(1.1kb), TRPC3 (0.8kb), and Nav1.9 were amplified
with gene-specific sets of PCR primers and cDNA templates pre-
pared from P0 mouse DRG. For immunostaining on frozen sections,
the embryos were collected in ice-cold PBS, fixed in 4% paraformal-
dehyde in PBS, and saturated with 20% sucrose in PBS overnight at
4ºC. For adult mice, after perfused with 4% paraformaldehyde in
PBS, dorsal root ganglia were dissected and collected in 4% para-
formaldehyde for 1 hr and saturated with 20% sucrose in PBS over-
night at 4ºC. Adjacent sections of 14 mm thickness were blocked with
1%BSA plus 0.1% Triton in PBS for 1 hr and incubated at 4ºC over-
night with the following cell-type-specific antibodies: rabbit or
guinea pig anti-Runx1 (T. Jessell, Columbia University), IB4-Biotin
(10 mg/ml, Sigma), and Rabbit TrkA (L. Reichardt, UCSF). Runx1 an-
tibody (1:4000) was against the peptide sequence GRASGMTSL
SAELSSRL and prepared in Jessell lab. The specificity of Runx1 an-
tibody was confirmed by the matching of its normal expression and
the elimination of its staining in Runx1–/– DRG. The primary antibod-
ies were detected with species-specific fluorescence-conjugated
secondary antibodies.
For in situ hybridization combined with Runx1 fluorescent immu-
nostaining or IB4 staining, in situ hybridization was first performed
without proteinase K treatment, followed by immunostaining with
Runx1 antibody or by incubation with fluorescence-conjugated
IB4. The in situ signals were photographed under transluminescent
light and converted into pseudo-red fluorescent color, whereas
Runx1 protein was detected with Alexa 488-conjugated secondary
antibodies (Molecular Probes).
For double staining of TRPM8 mRNA and Ret protein (Figure 6), in
situ hybridization with digoxenin (dig)-labeled TRPM8 probe was
first performed without proteinase K treatment. The slide sections
were blocked in 1% BSA plus 0.1% Triton in PBS for 1 hr, followed
by immunostaining with goat anti-Ret antibody (Molecular Probes)
and Alexa 488-conjugated secondary antibodies (Molecular
Probes). After fluorescent images were acquired under fluorescent
microscope, the slide sections were blocked with 10% goat serum,
incubated with alkaline phosphatase (AP)-conjugated goat anti-dig
antibody (Roche), followed by AP reaction with NBT/BCIP substrate
to generate purple staining for TRPM8 mRNA. The in situ signals
were then photographed under transluminescent light and con-
verted into pseudo-red fluorescent color. The Ret fluorescent im-
ages (green) were then carefully overlaid with TRPM8 images (red).
This reverse procedure allowed double staining with two antibodies
made in goats.
Cell Counting
To count total DRG neurons, we dissected L5 DRG from three pairs
of Runx1–/– and control Runx1F/F mice, fixed, and embedded, sec-
tioned with 10 mm thickness, hybridized with the panneural marker
SCG10, and numbers of SCG10+ neurons were counted. Only cells
containing nuclei were counted. To determine the percentages of
neurons expressing molecular markers, we prepared six adjacent
sets of sections from each L4 or L5 DRG and probed separately
with six different probes, one of which was the panneuronal marker
SCG10 to determine the total number of neurons so that percen-
tages can be calculated. Four to eight independent L4 and L5
DRG were used for each counting. Our counting is different from
what most people did. Instead of relying on morphology to identify
neurons, we determine the total neuron number by counting cells
expressing SCG10. Our methods allow us to determine some very
small sensory neurons. The in situ hybridization methods also led
us to identify Ret+ neurons that expressed at medium/low levels.Surgery
The spared nerve injury (SNI) model was performed on Runx1–/– and
control Runx1F/F mice as described for rats (Decosterd and Woolf,
2000). Briefly, animals were anesthetized with isoflurane (3% induc-
tion, 2% maintenance). An incision was made on the lateral thigh,
and the underlying muscle was separated to expose the sciatic
nerve. The three terminal branches of the sciatic nerve (tibial, com-
mon peroneal, and sural nerves) were carefully separated while min-
imizing any contact with or stretching of the sural nerve. The tibial
and common peroneal nerves were then individually ligated with
6.0 silk and cut distally. 2–3 mm of each nerve distal to the ligation
was removed. The muscle incision was closed with silk sutures
and the skin with surgical staples. For CFA-mediated inflammation,
mice were briefly anesthetized with isoflurane (2–3 min), and 15 ml of
complete Freund’s adjuvant (CFA) was injected into the plantar sur-
face of the left hindpaw. The thickness of the feet, before and 2 days
after CFA injection, were measured to examine inflammatory re-
sponses. In five Runx1F/F control mice, the thickness of the feet in-
creased from 2.20 6 0.05 mm to 3.45 6 0.30 mm (t test, p < 0.01),
and five Runx1–/– Mice show a similar increase, from 2.19 6 0.08
mm to 3.65 6 0.12 mm (t test, p < 0.001). There is no significant dif-
ference in the thickness of CFA-injected feet between Runx1F/F con-
trol versus Runx1–/– mice (p = 0.11, with p < 0.05 considered as sig-
nificant).
Behavioral Testing
All animals were acclimatized to the behavioral testing apparatus on
at least three ‘‘habituation’’ sessions. After habituation, at least two
baseline measures were obtained for each of the behavioral tests on
two separate occasions the week before surgery. After the surgical
procedures (day 0), the behavioral tests were performed at defined
intervals. The tester was blinded to the genotype of each animal.
To measure mechanical pain, we placed animals on an elevated
wire grid and the lateral plantar surface of the hindpaw stimulated
with von Frey monofilaments (0.0174–4.57 g) or pinprick. The with-
drawal threshold for the von Frey assay was determined as the fila-
ment at which the animal withdrew its paw at least twice in ten appli-
cations. The pinprick was measured as duration of time that the
animal elevated or licked the paw over a 20 s period immediately af-
ter the pinprick. To measure cold pain, we placed animals on an el-
evated wire grid. A drop of acetone was applied to the plantar hind-
paw with a feeding tube attached to a syringe. The duration of time
that the animal elevated or licked the paw over a 90 s period imme-
diately after application of the acetone drop was measured. To mea-
sure heat pain, we placed mice on a hot plate (Ugo Basile, Italy) and
the latency to hindpaw flicking, licking, or jumping measured. The
hot plate was set to three difference temperatures, 50ºC, 52ºC,
and 55ºC, and all animals were tested sequentially at each temper-
ature with at least 5 min between tests. A cutoff time of 60 s was
used for testing at 50ºC. To measure capsaicin-evoked pain, mice
were given a 2.5 mg/10 ml intraplantar injection of capsaicin (in
12.5% ethanol) and immediately placed in the behavioral testing ap-
paratus, and the duration of hindpaw licking or raising was mea-
sured for a period of 5 min.
Statistical Analyses of Pain Behaviors
Baseline data (and all nonprocedural testing data) was taken as the
mean of two tests performed. Post-CFA data was taken from a single
test performed 2 days postinjection. Postsurgery behavioral data
were analyzed by Student’s t test when comparing two groups
(Graphpad Prism, Graphpad, San Diego, CA) and two-way repeated
measures ANOVA followed by Bonferroni’s posttest for time
courses of two or more groups (R, v. 1.7.0, R Development Core
Team, Vienna, Austria). Log data was used for statistical analysis
of von Frey results. p < 0.05 was accepted as statistical significance.
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